US Stock MarketDetailed Quotes

BCAB BioAtla

Watchlist
  • 0.692
  • -0.498-41.82%
Close Dec 20 16:00 ET
  • 0.739
  • +0.047+6.75%
Post 19:59 ET
33.47MMarket Cap-0.41P/E (TTM)

About BioAtla Company

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

Company Profile

SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees65
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708
Websitehttp://www.BioAtla.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay M. Short,PhD
  • Chairman of the Board and Chief Executive Officer
  • 3.30M
  • Dr. Eric Sievers, M.D.
  • Chief Medical Officer
  • 1.32M
  • Richard A. Waldron
  • Senior Vice President and Chief Financial Officer
  • 1.24M
  • Christian Vasquez
  • Chief Accounting Officer, Controller and Corporate Secretary
  • --
  • Scott A. Smith
  • Director
  • 1.27M
  • Dr. Lawrence J. Steinman, M.D.
  • Independent Director
  • 161.19K
  • Sylvia McBrinn
  • Independent Director
  • 164.57K
  • Edward Williams
  • Independent Director
  • 168.94K
  • Dr. Susan Moran, M.D.
  • Independent Director
  • 158.19K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 180.44K
Heat List
US
Overall
Symbol
Price
% Chg

No Data